FRCPC MD - VBI Vaccines Chief Officer

Insider

FRCPC MD is Chief Officer of VBI Vaccines
Age 67
Phone617 830 3031
Webhttps://www.vbivaccines.com

VBI Vaccines Management Efficiency

The company has return on total asset (ROA) of (0.2915) % which means that it has lost $0.2915 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.1959) %, meaning that it created substantial loss on money invested by shareholders. VBI Vaccines' management efficiency ratios could be used to measure how well VBI Vaccines manages its routine affairs as well as how well it operates its assets and liabilities.
VBI Vaccines currently holds 53.04 M in liabilities with Debt to Equity (D/E) ratio of 0.32, which is about average as compared to similar companies. VBI Vaccines has a current ratio of 2.24, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about VBI Vaccines' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Eli WallaceBridgeBio Pharma
57
FACS FACSAllogene Therapeutics
73
Dr DVMiBio, Common Stock
55
Nick DeLongiBio, Common Stock
N/A
Brant BiehnVaxart Inc
N/A
CPA MSTArdelyx
50
CPA JDJaguar Animal Health
60
Frank McCormickBridgeBio Pharma
75
FACP MDOcugen Inc
N/A
Thomas SchlumpbergerAnixa Biosciences
N/A
CPA CPAOcugen Inc
47
Kimia KeshtbodArdelyx
N/A
Daniel MDTonix Pharmaceuticals Holding
N/A
Michael HoffmanAnnovis Bio
69
Stephen ChengAllogene Therapeutics
N/A
Joseph CPAAurinia Pharmaceuticals
51
Claudine BruckAnnovis Bio
65
Reid McCarthyAnnovis Bio
66
Vijay TammaraOcugen Inc
64
William JDAkero Therapeutics
51
Cezar MBAVaxart Inc
51
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts. Vbi Vaccines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 149 people. VBI Vaccines (VBIV) is traded on NASDAQ Exchange in USA and employs 131 people.

Management Performance

VBI Vaccines Leadership Team

Elected by the shareholders, the VBI Vaccines' board of directors comprises two types of representatives: VBI Vaccines inside directors who are chosen from within the company, and outside directors, selected externally and held independent of VBI. The board's role is to monitor VBI Vaccines' management team and ensure that shareholders' interests are well served. VBI Vaccines' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, VBI Vaccines' outside directors are responsible for providing unbiased perspectives on the board's policies.
Adam Buckley, Vice President - Operations and Project Management
FRCPC MD, Chief Officer
FCMA FCMA, CEO Pres
Christopher McNulty, CFO and Head of Business Development
Nicole Anderson, Director Relations
Avi Mazaltov, Global SciVac
Misha Nossov, Senior Europe
David Anderson, Chief Scientific Officer
Jeffery FCMA, CEO President
Nell Beattie, Chief Officer
Athena Kartsaklis, Principal Financial and Accounting Officer, Senior Vice President - Finance, Chief Compliance Officer, Corporate Controller
John Dillman, Chief Officer

VBI Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is VBI Vaccines a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in VBI Stock

If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets